This inventor holds 2 USPTO granted patents. Top assignee: Nidek Co., Ltd.. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2010
Title: Tomomitsu Miyoshi: Innovator in Ophthalmic Treatment Technologies
Introduction
Tomomitsu Miyoshi is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of ophthalmic treatment, focusing on methods and apparatuses that aim to improve retinal health. With a total of 2 patents, his work is paving the way for advancements in eye care.
Latest Patents
Miyoshi's latest patents include an innovative ophthalmic treatment stimulation method designed to inhibit the death of retinal cells. This method involves a two-step process where electrodes are strategically placed outside the eye to provide electrical stimulation to the retinal cells. The first step includes positioning a positive and a negative electrode, with at least one electrode placed on the cornea or sclera. The second step generates an electrical stimulation pulse with an electric current set between 20 µA and 300 µA. Additionally, he has developed an ophthalmic treatment apparatus that features an electrode for applying electrical stimulation to retinal cells, connected to a pulse generator that produces the same range of electrical stimulation.
Career Highlights
Miyoshi is currently employed at Nidek Co., Ltd., a company known for its commitment to developing advanced medical technologies. His work at Nidek has allowed him to focus on innovative solutions for eye treatment, contributing to the company's reputation in the ophthalmic field.
Collaborations
Miyoshi collaborates with esteemed colleagues such as Takashi Fujikado and Yutaka Fukuda. Their combined expertise enhances the research and development efforts at Nidek, fostering an environment of innovation.
Conclusion
Tomomitsu Miyoshi's contributions to ophthalmic treatment technologies reflect his dedication to improving eye health. His innovative patents and collaborations position him as a key figure in the advancement of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile